Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00564_DB01142_nanopub.RAV6H_icFzvK_GQ9_iYizOc72hjqJ7UUPPaFIgDuC2seU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00564_DB01142 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00564_DB01142 label "DDI between Carbamazepine and Doxepin - Carbamazepine may decrease the serum concentration of the tricyclic antidepressant, doxepin, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if carbamazepine is initiated, discontinued or dose changed. [drugbank_resource:DB00564_DB01142]" assertion.
- drugbank_resource:DB00564_DB01142 identifier "drugbank_resource:DB00564_DB01142" assertion.
- drugbank_resource:DB00564_DB01142 title "DDI between Carbamazepine and Doxepin - Carbamazepine may decrease the serum concentration of the tricyclic antidepressant, doxepin, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if carbamazepine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00564 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00564_DB01142 assertion.
- drugbank:DB01142 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00564_DB01142 assertion.